Home/Filings/4/0000950170-24-032246
4//SEC Filing

Zeiher Bernhardt G 4

Accession 0000950170-24-032246

CIK 0001658551other

Filed

Mar 14, 8:00 PM ET

Accepted

Mar 15, 4:35 PM ET

Size

5.4 KB

Accession

0000950170-24-032246

Insider Transaction Report

Form 4
Period: 2024-03-14
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-03-14+50,00050,000 total
    Exercise: $3.17Exp: 2034-03-13Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]One-third of the shares subject to the option shall vest on the first anniversary of the date of grant, and the remaining two-thirds will vest in equal monthly installments over two years, provided, however, that all vesting shall cease if the director resigns from the Board or otherwise ceases to serve as a director of the Issuer.

Documents

1 file

Issuer

Amylyx Pharmaceuticals, Inc.

CIK 0001658551

Entity typeother

Related Parties

1
  • filerCIK 0001971421

Filing Metadata

Form type
4
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 4:35 PM ET
Size
5.4 KB